Comprehensive Study Of Cardiac Rhythm Management (CRM) Global Market 2016 : Medtronic, St. Jude Medical, Boston Scientific

Researchmoz added Most up-to-date research on "Global Cardiac Rhythm Management (CRM) Market Report: 2016 Edition" to its huge collection of research reports.

Cardiac rhythm management (CRM) is a well-established segment of the cardiology devices market. CRM majorly consists of devices such as implantable cardioverter defibrillators (ICD), implantable pacemakers, and other CRM monitoring devices. Cardiac rhythm management devices are commonly used for the treatment of arrhythmias specifically superventricular arrhythmias (SVA) and ventricular arrhythmias (VA) and heart failure. CRM devices can be very efficient in decreasing the number of Sudden Cardiac Death (SCD). SCD is an unexpected death due to cardiac causes occurring in a short time period (generally within 1 hour of symptom onset) in a person with known or unknown cardiac disease.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=590581

The emerging markets are offering significant potential for companies able to establish distribution channels in the region. However, low reimbursement and costs of living provide intense pricing pressure for market entrants. With limited financial resources available, current devices are largely unaffordable in developing countries, and significant reductions are expected in future as manufacturing operations improve and distribution becomes more global. In response to significant cost concerns, there are many companies which are developing value-tier platforms that enable the sale of lower-cost devices. As physician use and adoption continues to increase in these regions, significant market expansion is expected.

The report provides a comprehensive study of global cardiac rhythm management (CRM) market and also the regional markets. The competition in the global CRM market is intense among large players like Medtronic, St. Jude Medical and Boston Scientific. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.

The key factors driving the growth of the CRM market are growing consumption of tobacco and alcohol, rising global population, rising healthcare expenditure, the rise of irrigated RF ablation catheter device, expansion in emerging markets and increasing prevalence of cardiac arrhythmias. Some of the noteworthy trends and developments of this industry are new product launch, rising demand of leadless pacemaker, ICD procedure growth trend, increased adoption of subcutaneous ICD, introduction of quadripolar lead devices. However, the expansion of market is hindered by regulatory and environment issues.

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-cardiac-rhythm-management-crm-market-report-2016-edition-report.html/toc

Table of Content

1. Market Overview
1.1 Cardiac Rhythm Management (CRM) Devices
1.2 Types of Cardiac Rhythm Management (CRM) Devices
1.2.1 Catheter Ablation
1.2.2 Cardiac Resynchronization Therapy (CRT)
1.2.3 Implantable CardioverterDefibrillator (ICD)
1.2.4 Pacemakers

2. Cardiac Rhythm Management Analysis
2.1 Global CRM Market

Annual Market Value
Quarterly Market Value
Growth Rate

2.1.1 Global ICD Market

Annual Market Value
Quarterly Market Value
Growth Rate

2.1.2 Global Pacemaker Market

Annual Market Value
Quarterly Market Value
Growth Rate

2.1.3 Global Cather Ablation Market

Market Volume
Market Segments

2.2 The US

CRM Quarterly Market Value
ICD Annual Market Value
ICD Quarterly Market Value
Pacemaker Annual Market Value
Pacemaker Quarterly Market Value

3. Market Dynamics
3.1 Growth Drivers
3.1.1 Growing Consumption of Tobacco and Alcohol
3.1.2 Growing Ageing Population
3.1.3 Rising Obese Population
3.1.4 Accelerating Economic Growth
3.1.5 Rising Healthcare Expenditure
3.1.6 Rise of Irrigated RF Ablation Catheter Devices
3.1.7 Emerging Market Adoption to Increase Sales
3.1.8 Primary Prevention on the Rise Globally
3.1.9 Increasing Prevalence of Cardiac Arrhythmias
3.2 Trends and Developments
3.2.1 New Product Launch
3.2.2 Growth of Biventricular Therapy Device
3.2.3 Rising Demand for Leadless Pacemaker
3.2.4 ICD Procedure Growth Trend
3.2.5 Increased Adoption of Subcutaneous ICD
3.2.6 Introduction of Quadripolar Lead Devices
3.2.7 Pacemaker with Options for Magnetic Resonance Imaging
3.3 Challenges
3.3.1 Regulatory Issues
3.3.2 Environment Issues

4. Competitive Landscape
4.1 Global Market
4.1.1 Global CRM Market
4.1.2 Global ICD Market
4.1.3 Global Pacemaker Market
4.2 The US
4.2.1 CRM Market
4.2.2 ICD Market
4.2.3 Pacemaker Market

Continue...

Global Cardiac Rhythm Management (CRM) Industry Key Trends, Size, Growth, Shares And Forecast Research Report 2015

Researchmoz added Most up-to-date research on "Global Cardiac Rhythm Management (CRM) Market Report: 2015 Edition" to its huge collection of research reports.

Cardiac rhythm management (CRM) is a well-established segment of the cardiology devices market. CRM majorly consists of devices such as Implantable Cardioverter Defibrillators (ICD), implantable pacemakers, and other CRM monitoring devices. Cardiac rhythm management devices are commonly used for the treatment of arrhythmias specifically superventricular arrhythmias (SVA) and ventricular arrhythmias (VA) and heart failure.

Cardiovascular device manufacturers are looking to capitalize growth in emerging economies, such as China, Brazil and India to offset declining growth they are experiencing in the US and Western markets. Factors such as rapidly increasing aging population, growing focus of multinational companies on emerging markets, improving and modernizing healthcare infrastructure, and huge burden of cardiovascular disease are propelling the growth of CRM market. The introduction of remote home-monitoring in emerging markets promises to make dramatic changes. It will decrease the number of patient hospital visits, a particularly attractive feature for customers living in remote regions far from access to healthcare.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=246771

The population requiring CRM therapy continues to grow as a result of increasing incidences of arrhythmia and heart failure due to the prevalence of serious risk factors, including obesity, diabetes, and hypertension. However, lack of awareness about sudden cardiac arrests, issues related to the use of defibrillator devices (external and implantable), and mounting regulatory and pricing pressures are hindering the growth of this market.

The report, “Global Cardiac Rhythm Management Market: 2015 Edition” analyzes the fundamentals and development of global cardiac rhythm management market globally and in the US. It also analyzes the major segments of the market – ICD and pacemaker. Apart from providing a competitive landscape of the market, the report also profiles the major companies including Medtronic Inc., Boston Scientific and St. Jude medical along with a discussion of their key financials and business strategies.

Table of Content

1. CRM: An Overview1.1 An Introduction
1.2 CRM Devices
1.2.1 Implantable Cardioverter Defibrillators (ICDs)
1.2.2 Pacemaker

2. Cardiac Rhythm Management Market
2.1 Global Market Size

- Market Value
- Annual/Quarterly Growth
- US/Outside US Market Breakdown
- US Market Growth

2.1.1 Implantable Cardiac Defibrillators (ICD) Market

- Market Value
- US/Outside US Market Breakdown

2.1.2 Pacing Systems Market

- Market Value
- US/Outside US Market Breakdown

3. Market Dynamics
3.1 Key Trends
3.1.1 Biventricular Therapy Growth
3.1.2 Increasing Demand from Emerging Markets
3.1.3 Shift towards Primary Prevention
3.1.4 ICD Procedure Growth Trend
3.1.5 Increased Adoption of Subcutaneous ICD
3.2.6 ICD, CRT-D, PPM Implant Volume Trend
3.2.7 ICD, CRT-D, PPM Implant Pricing Trend
3.2 Growth Drivers
3.2.1 Rising Ageing Population
3.2.2 Rising Obese Population
3.2.3 Rise in Consumption of Alcohol and Tobacco
3.2.4 Global Economic Development
3.2.5 Increasing Healthcare Expenditure
3.2.6 Increasing Incidence of Arrhythmia and Heart Failure
3.3 Challenges
3.3.1 Regulatory Issues
3.3.2 Environment Issues
3.3.3 Mounting Pricing Pressures
3.4 Significant Developments
3.4.1 Advanced Subcutaneous-ICDs (S-ICDs)
3.4.2 Leadless Pacemaker
3.4.3 Attain Performa Quadripolar Lead and Viva Quad CRT-Ds by Medtronic
3.4.4 Pacemaker with Options for Magnetic Resonance Imaging

4. Competitive Landscape
4.1 Global Competitive Scenario
4.1.1 CRM Market
4.1.2 ICD Market
4.1.3 Pacemaker Market
4.2 Competitive Scenario: The US
4.2.1 CRM Market
4.2.2 ICD Market
4.2.3 Pacemaker Market

5. Company Profiles
5.1 Medtronic Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies

- Focus on Research & Development
- Strategic Acquisitions & Investments

5.2 Boston Scientific
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies

- Growth through Innovation
- Expansion in Emerging Markets

5.3 St. Jude Medical
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies

- Strategic Acquisitions
- Innovation through Research & Development

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=246771

Global Cardiac Rhythm Management (CRM) Market Key Trends, Size, Growth, Shares And Forecast Research Report 2016

Researchmoz added Most up-to-date research on "Global Cardiac Rhythm Management (CRM) Market Report: 2016 Edition" to its huge collection of research reports.

Cardiac rhythm management (CRM) is a well-established segment of the cardiology devices market. CRM majorly consists of devices such as implantable cardioverter defibrillators (ICD), implantable pacemakers, and other CRM monitoring devices. Cardiac rhythm management devices are commonly used for the treatment of arrhythmias specifically superventricular arrhythmias (SVA) and ventricular arrhythmias (VA) and heart failure. CRM devices can be very efficient in decreasing the number of Sudden Cardiac Death (SCD). SCD is an unexpected death due to cardiac causes occurring in a short time period (generally within 1 hour of symptom onset) in a person with known or unknown cardiac disease.

The emerging markets are offering significant potential for companies able to establish distribution channels in the region. However, low reimbursement and costs of living provide intense pricing pressure for market entrants. With limited financial resources available, current devices are largely unaffordable in developing countries, and significant reductions are expected in future as manufacturing operations improve and distribution becomes more global. In response to significant cost concerns, there are many companies which are developing value-tier platforms that enable the sale of lower-cost devices. As physician use and adoption continues to increase in these regions, significant market expansion is expected.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=590581

The report provides a comprehensive study of global cardiac rhythm management (CRM) market and also the regional markets. The competition in the global CRM market is intense among large players like Medtronic, St. Jude Medical and Boston Scientific. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.

The key factors driving the growth of the CRM market are growing consumption of tobacco and alcohol, rising global population, rising healthcare expenditure, the rise of irrigated RF ablation catheter device, expansion in emerging markets and increasing prevalence of cardiac arrhythmias. Some of the noteworthy trends and developments of this industry are new product launch, rising demand of leadless pacemaker, ICD procedure growth trend, increased adoption of subcutaneous ICD, introduction of quadripolar lead devices. However, the expansion of market is hindered by regulatory and environment issues.

Table of Content

1. Market Overview1.1 Cardiac Rhythm Management (CRM) Devices   
1.2 Types of Cardiac Rhythm Management (CRM) Devices
1.2.1 Catheter Ablation   
1.2.2 Cardiac Resynchronization Therapy (CRT)   
1.2.3 Implantable CardioverterDefibrillator (ICD)   
1.2.4 Pacemakers

2. Cardiac Rhythm Management Analysis
2.1 Global CRM Market   

    Annual Market Value
    Quarterly Market Value
    Growth Rate

2.1.1 Global ICD Market   

    Annual Market Value
    Quarterly Market Value
    Growth Rate

2.1.2 Global Pacemaker Market

    Annual Market Value
    Quarterly Market Value
    Growth Rate

2.1.3 Global Cather Ablation Market   

    Market Volume
    Market Segments

2.2 The US

    CRM Quarterly Market Value
    ICD Annual Market Value
    ICD Quarterly Market Value
    Pacemaker Annual Market Value
    Pacemaker Quarterly Market Value

3. Market Dynamics
3.1 Growth Drivers
3.1.1 Growing Consumption of Tobacco and Alcohol   
3.1.2 Growing Ageing Population   
3.1.3 Rising Obese Population   
3.1.4 Accelerating Economic Growth   
3.1.5 Rising Healthcare Expenditure   
3.1.6 Rise of Irrigated RF Ablation Catheter Devices   
3.1.7 Emerging Market Adoption to Increase Sales   
3.1.8 Primary Prevention on the Rise Globally   
3.1.9 Increasing Prevalence of Cardiac Arrhythmias
3.2 Trends and Developments
3.2.1 New Product Launch   
3.2.2 Growth of Biventricular Therapy Device   
3.2.3 Rising Demand for Leadless Pacemaker   
3.2.4 ICD Procedure Growth Trend   
3.2.5 Increased Adoption of Subcutaneous ICD   
3.2.6 Introduction of Quadripolar Lead Devices   
3.2.7 Pacemaker with Options for Magnetic Resonance Imaging
3.3 Challenges
3.3.1 Regulatory Issues   
3.3.2 Environment Issues

4. Competitive Landscape
4.1 Global Market
4.1.1 Global CRM Market   
4.1.2 Global ICD Market   
4.1.3 Global Pacemaker Market
4.2 The US
4.2.1 CRM Market   
4.2.2 ICD Market   
4.2.3 Pacemaker Market

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=590581